Combined Letrozole and Clomiphene Citrate Versus Letrozole Alone in Ovulation Induction for Polycystic Ovarian Syndrome Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Reproductive Sciences · 2025
DOI: 10.1007/s43032-025-01979-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reproductive Sciences, 2025. Verfasst von Zainah Abdulbari Alhebshi und 9 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia. Alhebshizainah@gmail.com. Hauptthemen laut MEDLINE: Letrozole, Polycystic Ovary Syndrome, Clomiphene, Ovulation Induction. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Polycystic ovarian syndrome (PCOS) is a leading cause of infertility due to chronic anovulation. Letrozole is the first-line treatment for ovulation induction, but combination therapy with clomiphene citrate (CC) may enhance outcomes. We conducted a systematic search of three databases until October 2024, including randomized controlled trials (RCTs). Bias was assessed using the Revised Cochrane risk of bias tool (RoB 2). Six RCTs with 619 PCOS patients were included. The combination of Letrozole and CC resulted in a higher, though non-significant, ovulation rate (53.74%) vs. Letrozole alone (40.08%) (OR 1.22, 95% CI [0.88, 1.69], P = 0.23). Lower-dose combination therapy (50 mg CC + 2.5 mg Letrozole) significantly improved ovulation (OR 4.45, 95% CI [2.19, 9.08], P 15 mm (OR 4.09, 95% CI [1.94, 8.60], P < 0.001), with no significant differences in endometrial thickness, follicular size, or progesterone levels. Side effects were similar, though hot flushes were more common with combination therapy (OR 2.99, 95% CI [1.23, 7.23], P = 0.02). Our results support lower-dose combination therapy for improved ovulation, follicle count, and pregnancy outcomes while reducing miscarriage risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia. Alhebshizainah@gmail.com.
- College of Medicine, Bisha University, Bisha, Saudi Arabia.
- Postgraduate Training Program for Preventive Medicine, Ministry of Health, Jeddah, Saudi Arabia.
- College of Medicine, Majmaah University, Al Majmaah, Saudi Arabia.
- Unaizah College of Medicine and Medical Sciences, Qassim University, Qassim, Saudi Arabia.
- General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
ORCID-Profile: Zainah Abdulbari Alhebshi, Ayesha Jamal
Zitieren
APA
Alhebshi, Z. A., Alqarni, D. H., Najjar, A. A., Alshalahi, S. S., Alhatlani, R. A., Jamal, A., Wasaya, H. M. I., Almehmadi, M., Alrafi, M. A., & AlHabardi, N. (2025). Combined Letrozole and Clomiphene Citrate Versus Letrozole Alone in Ovulation Induction for Polycystic Ovarian Syndrome Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Reproductive Sciences. https://doi.org/10.1007/s43032-025-01979-4
Vancouver
Alhebshi ZA, Alqarni DH, Najjar AA, Alshalahi SS, Alhatlani RA, Jamal A, et al. Combined Letrozole and Clomiphene Citrate Versus Letrozole Alone in Ovulation Induction for Polycystic Ovarian Syndrome Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Reproductive Sciences. 2025. doi:10.1007/s43032-025-01979-4
BibTeX
@article{Alhebshi2025,
author = {Alhebshi, Zainah Abdulbari and Alqarni, Dalia Hamed and Najjar, Albaraa A and Alshalahi, Seham Shafi and Alhatlani, Rama A and Jamal, Ayesha and Wasaya, Hanan Muhammed Ismail and Almehmadi, Mariah and Alrafi, Maria Abdulaziz and AlHabardi, Nadiah},
title = {Combined Letrozole and Clomiphene Citrate Versus Letrozole Alone in Ovulation Induction for Polycystic Ovarian Syndrome Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials},
journal = {Reproductive Sciences},
year = {2025},
doi = {10.1007/s43032-025-01979-4}
}
EUVIMED